SPOT-mRNA01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SPOT-mRNA01, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Preliminary Evaluation of the Safety and Tolerability of SPOT-mRNA01 Subcutaneously Administered in Healthy Subjects [Phase 1]